Southampton university granted £833k funding for tuberculosis research

£833k funding for tuberculosis research

£833k funding for tuberculosis research

First published in News
Last updated

A HAMPSHIRE university has been awarded £833,260 to develop new treatments to fight tuberculosis.

The University of Southampton tuberculosis research group will use the funding from the US National Institutes of Health to develop new treatments for the disease. Researchers will investigate preventing enzymes from causing lung damage, thereby boosting the body’s ability to control infection and stop ongoing illness and death. The research continues an established collaboration between the university, Public Health England, Government’s military science facility Porton Down and Columbia University, New York.

Dr Paul Elkington, who leads tuberculosis research at the university, said: “Tuberculosis remains a globally important disease and continues to kill over 3,000 people every day, but standard treatment has remained unchanged for over 30 years. “This award will be critical to taking our basic research findings towards new treatments that will limit the lung destruction in tuberculosis, thereby reducing mortality and improving outcomes.”

Tuberculosis is a bacterial infection spread through inhaling tiny droplets generated from the coughing of an infected person.

In 2012, it claimed 1.3 million lives, the vast majority of them in developing nations.

Patients with lung cavities are at much greater risk of developing drug-resistance disease, which is a worsening global phenomenon and has resulted in the emergence of untreatable totally drug-resistant strains.

Comments

Comments are closed on this article.

Send us your news, pictures and videos

Most read stories

Local Info

Enter your postcode, town or place name

About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree